CANCER LETTERS 581 (2024) 216528 216529 EPIGENETIC APPROACHES TO EPITHELIAL OVARIAN CANCER

被引：0
|
作者：
Zhang, Rugang [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA
来源：
CANCER LETTERS | 2024年 / 581卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IS1
引用
收藏
页数：1
相关论文
共 50 条
  • [31] CANCER LETTERS 581 (2024) 216528 216545 BYPASSING THE TOLLWAY; A NOVEL PATH TO TLR4 INDEPENDENT STEMNESS REGULATION
    Standing, David
    Anant, Shrikant
    CANCER LETTERS, 2024, 581
  • [32] CANCER LETTERS 581 (2024) 216528 216535 SUPER-GIANT CELLS: TOWARD UNDERSTANDING TUMOR ORIGINS ON THE ORGANISMAL LEVEL
    Liu, Jinsong
    CANCER LETTERS, 2024, 581
  • [33] CANCER LETTERS 581 (2024) 216528 216555 MECHANISM OF RESISTANCE TO A PHASE-II IDELALISIB-BASED CLINICAL TRIAL IN CLL
    Mamidi, Murali K.
    Mahmud, Hasan
    Maiti, Guru P.
    Mendez, Mariana T.
    Fernandes, Stacey M.
    Vesely, Sara K.
    Holter-Chakrabarty, Jennifer
    Brown, Jennifer R.
    Ghosh, Asish K.
    CANCER LETTERS, 2024, 581
  • [34] Epithelial Ovarian Cancer in 2024
    Jones, T.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2025, 65
  • [35] CANCER LETTERS 581 (2024) 216528 216550 LYSINE DEMETHYLASE KDM1A/LSD1 INHIBITION ENHANCES ESTROGEN RECEPTOR BETA-MEDIATED TUMOR SUPPRESSION IN OVARIAN CANCER
    Sareddy, Gangadhara R.
    CANCER LETTERS, 2024, 581
  • [36] CANCER LETTERS 581 (2024) 216528 216536 SMAC MIMETICS SYNERGIZE WITH HDAC INHIBITORS THROUGH BY ENHANCING AUTOCRINE TNF-ALPHA SIGNALING
    Shibuya, Yusuke
    Kudo, Kei
    Zeligs, Kristen P.
    Anderson, David
    Hernandez, Lidia
    Ning, Franklin
    Cole, Christopher B.
    Fergusson, Maria
    Kedei, Noemi
    Lyons, John
    Taylor, Jason
    Korrapati, Soumya
    Annunziata, Christina M.
    CANCER LETTERS, 2024, 581
  • [37] CANCER LETTERS 581 (2024) 216528 216553 TARGETING PGE2/IL-23 NEXUS IN TME FOR CRC PREVENTION AND TREATMENT
    Rao, Chinthalapally V.
    CANCER LETTERS, 2024, 581
  • [38] Epigenetic biomarkers in epithelial ovarian cancer
    Gloss, Brian S.
    Samimi, Goli
    CANCER LETTERS, 2014, 342 (02) : 257 - 263
  • [39] Epigenetic therapies for chemoresensitization of epithelial ovarian cancer
    Matei, Daniela E.
    Nephew, Kenneth P.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (02) : 195 - 201
  • [40] CANCER LETTERS 581 (2024) 216528 216537 NOS2 AND COX2 PREDICTS POOR OUTCOME IN ER- BREAST CANCER THROUGH IMMUNOSUPPRESSION. NOVEL STRATEGIES TO OVERCOME IMMUNOSUPPRESSION
    Wink, David A., Jr.
    CANCER LETTERS, 2024, 581
12345